BackTerns Pharmaceuticals Overview

Terns Pharmaceuticals Net Income

Profitability analysis for TERN.

Quarterly Net Income

-$23.57M
↓ 8.13% YoY

As of Dec 2025

Annual Net Income (TTM)

-$96.21M
↓ 8.28% YoY

Trailing 12 months ending Dec 2025

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin